Osmotic opening of the blood-brain barrier: Principles, mechanism, and therapeutic applications

Cellular and Molecular Neurobiology

Volumn 20, Issue 2, 2000, Pages 217-230

  Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arabinose; Blood brain barrier; Brain; Bulk flow; Capillary; Chemotherapy; Drug; Mannitol; Osmosis; Permeability; Shrinkage; Tight junctions; Tumor

Indexed keywords

ARABINOSE; CYCLOPHOSPHAMIDE; HYPERTONIC SOLUTION; MANNITOL; METHOTREXATE; PROCARBAZINE; VIRUS VECTOR;

BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN TUMOR; CYTOSKELETON; ENDOTHELIUM CELL; GENE THERAPY; HUMAN; NERVOUS SYSTEM INJURY; NEUTRON CAPTURE THERAPY; OSMOSIS; PERMEABILITY; PRIORITY JOURNAL; REVIEW; SEIZURE; TIGHT JUNCTION; VASODILATATION;

ANIMALS; ARABINOSE; BLOOD-BRAIN BARRIER; CAROTID ARTERIES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTONIC SOLUTIONS; INFUSIONS, INTRA-ARTERIAL; MANNITOL;

ANIMALIA;

EID: 0033974507     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007049806660     Document Type: Review

References (98)

1. Abbott, N. J., and Revest, P. A. (1991). Control of brain endothelial permeability. Cerebrovasc. Brain Metab. Rev. 3:39-72.
2. 3H]dextran. Exp. Neurol. 97:686-696.
3. Armstrong, B. K., Smith, Q. R., Rapoport, S. I., Strohalm, J., Kopecek, J., and Duncan, R. (1989). Osmotic opening of the blood-brain barrier permeability to n-(2-hydroxypropyl) methacrylamide copolymers. Effect of polymer Mw, charge and hydrophobicity. J. Control. Release 10:27-35.
4. Barranger, J. A., Rapoport, S. I., Fredericks, W. R., Pentchev, P. G., MacDermot, K. D., Steusing, J. K., and Brady, R. O. (1979). Modification of the blood-brain barrier: Increased concentration and fate of enzymes entering the brain. Proc. Natl. Acad. Sci. USA 76:481-485.
5. Barth, R. F., Yang, W., Rotaru, J. H., Moeschberger, M. L., Joel, D. D., Nawrocky, M. H., Goodman, J. H., and Soloway, A. H. (1997). Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Cancer Res. 57:1129-1136.
6. Brightman, M. W., Hori, M., Rapoport, S. I., Reese, T. S., and Westergaard, E. (1973). Osmotic opening of tight junctions in cerebral endothelium. J. Comp. Neurol. 152:317-325.
7. Brownson, E. A., Abbruscato, T. J., Gillespie, T. J., Hruby, V. J., and Davis, T. P. (1994). Effect of peptidases at the blood brain barrier on the permeability of enkephalin. J. Pharmacol. Exp. Ther. 270:675-680.
8. Chamberlain, M. C., Murovic, J. S., and Levin, V. A. (1988). Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38:1371-1374.
9. Chi, O. Z., Lu, X., Wei, H. M., Williams, J. A., and Weiss, H. R. (1996). Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth. Analg. 83:336-341.
10. Chi, O. Z., Chang, Q., Wang, G., and Weiss, H. R. (1997). Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth. Analg. 84:370-375.
11. 125I]albumin and Evans blue from blood into brain following unilateral osmotic opening of the blood-brain barrier. Brain Res. 145:292-301.
12. Collander, R. (1937). The permeability of plant protoplasts to non-electrolytes. Trans. Faraday Soc. 33:985-990.
13. Cosolo, W. C., Martinello, P., Louis, W. J., and Christophidis, N. (1989). Blood-brain barrier disruption using mannitol: Time course and electron microscopic studies. Am. J. Physiol. 256:R443-R447.
14. Crossen, J. R., Goldman, D. L., Dahlborg, S. A., and Neuwelt, E. A. (1992). Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery 30:23-29.
15. Dahlborg, S. A., Henner, W. D., Crossen, J. R., Tableman, M., Petrillo, A., Braziel, R., and Neuwelt, E. A. (1996). Non-AIDS primary CNS lymphoma: The first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J. Sci. Am. 2:166-174.
16. DeAngelis, L. M. (1993). Cerebral lymphoma presenting as a nonenhancing lesion on a computed tomographic/magnetic resonance scan. Ann. Neurol. 33:308-311.
17. Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., and Cecchelli, R. (1997). A new function of the LDL receptor: Transcytosis of LDL through blood-brain barrier. J. Cell Biol. 138:877-889.
18. Dorovini-Zis, K., Sato, M., Goping, G., Rapoport, S. I., and Brightman, M. (1983). Ionic lanthanum passage across cerebral endothelium exposed to hyperosmotic arabinose. Acta Neuropathol. (Berlin) 60:49-60.
19. Dorovini-Zis, K., Bowman, P. D., Betz, A. L., and Goldstein, G. W. (1984). Hyperosmotic arabinose solutions open tight junctions between brain capillary endothelial cells in tissue culture. Brain Res. 302:383-386.
20. Fenstermacher, J. D., and Johnson, J. A. (1966). Filtration and reflection coefficients of the rabbit blood-brain barrier. Am. J. Physiol. 211:341-346.
21. Fishman, J. B., Rubin, J., Handrahan, J. V., Connor, J. R., and Fine, R. E. (1987). Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J. Neurosci. Res. 18:299-304.
22. Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., and Starzyk, R. M. (1991). Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl. Acad. Sci. USA 88:4771-4775.
23. Friden, P. M., Walus, L. R., Watson, P., Doctrow, S. R., Kozarich, J. W., Bäckman, C., Bergman, H., Hoffer, B., Bloom, F., and Granholm, A.-C. (1993). Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259:373-377.
24. Gjedde, A., Reith, J., Léger, G., Cumming, P., Yasuhara, Y., Guttman, M., and Kuwabara, H. (1995). Blood-brain barrier removal of DOPA: Role in regulation of dopamine synthesis and treatment of Parkinson's disease. In Greenwood, J., Begley, D., and Segal, M. (eds.), New Concepts of a Blood-Brain Barrier, Plenum Press, London, pp. 103-109.
25. Greig, N. H., Fredericks, W. R., Holloway, H. W., Soncrant, T. T., and Rapoport, S. I. (1988). Delivery of interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat. J. Pharmacol. Exp. Ther. 245:581-586.
26. Gumbiner, B. M. (1996). Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84:345-357.
27. Gumerlock, M. K., and Neuwelt, E. A. (1990). The effects of anesthesia on osmotic blood-brain barrier disruption. Neurosurgery 26:268-277.
28. Gumerlock, M. K., Belshe, B. D., Madsen, R., and Watts, C. (1992). Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: Patient series and literature review. J. Neurooncol. 12:33-46.
29. Gumerlock, M. K., York, D., and Durkis, D. (1994). Visual evoked responses as a monitor of intracranial pressure during hyperosmolar blood-brain barrier disruption. Acta Neurochir. Suppl. 60:132-135.
30. Hicks, J. T., Albrecht, P., and Rapoport, S. I. (1976). Entry of neutralizing antibody to measles into brain and cerebrospinal fluid of immunised momkeys following osmotic opening of the blood-brain barrier. Exp. Neurol. 53:768-779.
31. Hiesiger, E. M., Voorhies, R. M., Basler, G. A., Lipscuhtz, L. E., Posner, J. B., and Shapiro, W. R. (1986). Opening the blood-brain and blood-tumor barriers in experimental rat brain tumor: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann. Neurol. 19:50-59.
32. Inamura, T., Nomura, T., Bartus, R. T., and Black, K. L. (1994). Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J. Neurosurg. 81:752-758.
33. 2+ store in vascular endothelial cells. Am. J. Physiol. 273:C316-C322.
34. 125I]glial cell line-derived neurotrophic factor to the rat CNS following osmotic blood-brain barrier modification. Neurosci. Lett. 220:187-190.
35. 68Ga]EDTA. J. Cereb. Blood Flow Metab. 4:323-328.
36. Latker, C. H., Lynch, K. J., Shinowara, N. L., and Rapoport, S. I. (1986). The morphology of pial blood vessels of the frog, preserved by rapid freezing and freeze substitution. Brain Res. 375:186-192.
37. Levine, R. L., Fredericks, W. R., and Rapoport, S. I. (1985). Clearance of bilirubin from rat brain after reversible osmotic opening of the blood-brain barrier. Pediatr. Res. 19:1040-1043.
38. Lin, W. L. (1988). Leakage of blood-retinal barrier due to damaging effect of protamine sulfate on the endothelium. Acta Neuropathol. (Berl.) 76:427-431.
39. Lin, W., Paczynski, R. P., Kuppusamy, K., Hsu, C. Y., and Haacke, E. M. (1997). Quantitative measurements of regional cerebral blood volume using MRI in rats: effects of arterial carbon dioxide tension and mannitol. Magn. Reson. Med. 38:420-428.
40. Lowenstein, P. R., Morrison, E. E., Bain, D., Hodge, P., Preston, C. M., Clissold, P., Stow, N. D., Mckee, T. A., and Castro, M. G. (1994). Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro. Neuroscience 60:1059-1077.
41. Millay, R. H., Klein, M. L., Shults, W. T., Dahlborg, S. A., and Neuwelt, E. A. (1986). Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am. J. Ophthalmol. 102:626-632.
42. Muldoon, L. L., Nilaver, G., Kroll, R. A., Pagel, M. A., Breakefield, X. O., Chiocca, E. A., Davidson, B. L., Weissleder, R., and Neuwelt, E. A. (1995). Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am. J. Pathol. 147:1840-1851.
43. Nag, S. (1995). Role of the endothelial cytoskeleton in blood-brain barrier permeability to protein. Acta Neuropathol. (Berl.) 90:454-460.
44. Nagashima, T., Shijing, W., Mizoguchi, A., and Tamaki, N. (1994). A possible role of calcium ion in osmotic opening of blood-brain barrier. J. Auton. Nerv. Syst. 49 (Suppl.):S145-S149.
45. Neuwelt, E. A., Frenkel, E. P., Diehl, J., Vu, L. H., Rapoport, S. I., and Hill, S. A. (1980). Reversible osmotic blood-brain barrier disruption in humans: Implication for the chemotherapy of malignant brain tumors, Neurosurgery 7:44-52.
46. Neuwelt, E. A., Glasberg, M., Frenkel, E., and Barnett, P. (1983). Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: Neuropathological studies. Ann. Neurol. 14:316-324.
47. Neuwelt, E. A., Barnett, P. A., Hellstrom, I., Hellstrom, K. E., Beaumier, P., McCormick, C. I., and Weigel, R. M. (1988). Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res. 48:4725-4729.
48. Neuwelt, E. A., Dahlborg, S. A., Goldman, D., Dana, B., and Ramsey, F. L. (1989). Significant prolongation of survival of primary CNS lymphoma patients by combination chemotherapy given in association with osmotic blood-brain barrier disruption. Proc. Am. Assoc. Cancer Res. 30:264.
49. Neuwelt, E. A., Williams, P. C., Mickey, B. E., Frenkel, E. P., and Henner, W. D. (1994). Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption. Pediatr. Neurosurg. 21:16-22.
50. Neuwelt, E. A., Brummett, R. E., Remsen, L. G., Kroll, R. A., Pagel, M. A., McCormick, C. I., Guitjens, S., and Muldoon, L. L. (1996). In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res. 56:706-709.
51. 3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier. Cancer Res. 45:1092-1096.
52. Ohno, K., Pettigrew, K. D., and Rapoport, S. I. (1978). Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol. 235:H299-H307.
53. 2+ transients in endothelial cells from human umbilical vein. Proc. Natl. Acad. Sci. USA 91:2940-2944.
54. Okisaka, S., Kuwabara, T., and Rapoport, S. I. (1974). Selective destruction of the pigmented epithelium in the ciliary body of the eye. Science 184:1298-1299.
55. Olesen, S. P. (1987). Regulation of ion permeability in frog brain venules. Significance of calcium, cyclic nucleotides and protein kinase C. J. Physiol. (Lond.) 387:59-69.
56. Overton, E. (1895). Über die osmotischen Eigenschaften der lebenden Pflanzen und Tierzelle. Vierteljahresschr. Naturforsch. Ges. Zurich 40:159-201.
57. Pastan, I., Willingham, M. C., and Gottesman, M. (1991). Molecular manipulations of the multidrug transporter: A new role for transgenic mice. FASEB J. 5:2523-2528.
58. Rapoport, S. I. (1970). Effect of concentrated solutions on blood-brain barrier. Am. J. Physiol. 219:270-274.
59. Rapoport, S. I. (1976). Blood-Brain Barrier in Physiology and Medicine, Raven Press, New York, p. 316.
60. Rapoport, S. I. (1988). Osmotic opening of the blood-brain barrier. Ann. Neurol. 24:677-680.
61. Rapoport, S. I. (1991). Microinfarction: Osmotic BBB opening of microcrystals in infusate? J. Neurosurg. 74:685.
62. Rapoport, S. I. (1996). Modulation of blood-brain barrier permeability. J. Drug Target. 3:417-425.
63. Rapoport, S. I. (1997). Brain edema and the blood-brain barrier. In Welch, K. M. A., Caplan, L. R., Reis, D. J., Siesjö, B. K., and Weir, B. (eds.), Primer on Cerebrovascular Diseases, Academic Press, New York, pp. 25-28.
64. Rapoport, S. I., and Robinson, P. J. (1986). Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann. N.Y. Acad. Sci. 481:250-267.
65. Rapoport, S. I., and Robinson, P. J. (1990). A therapeutic role for osmotic opening of the blood-brain barrier. Re-evaluation of literature and of importance of source-sink relations between brain and tumor. In Johanson, B. B., Owman, C., and Widner, H. (eds.), Pathophysiology of the Blood-Brain Barrier, Long Term Consequences of Barrier Dysfunction for the Brain, Elsevier, Amsterdam, pp. 167-181.
66. Rapoport, S. I., and Thompson, H. K. (1973). Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits. Science 180:971.
67. Rapoport, S. I., Hori, M., and Klatzo, I. (1972). Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am. J. Physiol. 223:323-331.
68. Rapoport, S. I., Fredericks, W. R., Ohno, K., and Pettigrew, K. D. (1980). Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am. J. Physiol. 238:R421-R431.
69. 14C-Urea pharmacokinetics. Am. J. Physiol. 242:R339-R348.
70. Ravussin, P., Archer, D. P., Tyler, J. L., Meyer, E., Abou-Madi, M., Diksic, M., Yamamoto, L., and Trop, D. (1986). Effects of rapid mannitol infusion on cerebral blood volume. A positron emission tomographic study in dogs and man. J. Neurosurg. 64:104-113.
71. Reese, T. S., and Karnovsky, M. J. (1967). Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34:207-217.
72. Robinson, P. J., and Rapoport, S. I. (1987). Size selectivity of blood-brain barrier permeability at various times after osmotic opening. Am. J. Physiol. 253:R459-R466.
73. Robinson, P. J., and Rapoport, S. I. (1990). Model for drug uptake by brain tumors: Effects of osmotic treatment and of diffusion in brain. J. Cereb. Blood Flow Metab. 10:153-161.
74. Rosomoff, H. L. (1962). Distribution of intracranial contents after hypertonic urea. J. Neurosurg. 19:859-864.
75. Salahuddin, T. S., Johansson, B. B., Kalimo, H., and Olsson, Y. (1988). Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study. Acta Neuropathol. (Berl.) 77:5-13.
76. Sanovich, E., Bartus, R. T., Friden, P. M., Dean, R. L., Le, H. Q., and Brightman, M. (1995). Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res. 705:125-135.
77. Schinkel, A. H., Smit, J. J., van Telligen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., De Riele, H. P. J., Berns, A. J. M., and Borst, P. (1994). Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
78. Smith, Q. R. (1993). Drug delivery to brain and the role of carrier-mediated transport. Adv. Exp. Med. Biol. 331:83-93.
79. Staddon, J. M., and Rubin, L. L. (1996). Cell adhesion, cell junctions and the blood-brain barrier. Curr. Opin. Neurobiol. 6:622-627.
80. Suzuki, M., Iwasaki, Y., Yamamoto, T., Konno, H., and Kudo, H. (1988). Sequelae of the osmotic blood-brain barrier opening in rats. J. Neurosurg. 69:421-428.
81. Takada, T., Vistica, D. T., Greig, N. H., Purdon, D., Rapoport, S. I., and Smith, Q. R. (1992). Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Cancer Res. 52:2191-2196.
82. Takahashi, M., Tsutsui, H., Murayama, C., Miyazawa, T., and Fritz-Zieroth, B. (1996). Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier. Magn. Reson. Imaging 14:619-623.
83. Tator, C. H. (1972). Chemotherapy of brain tumors: uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice. J. Neurosurg. 37:1-8.
84. Tomiwa, K., Hazama, F., and Mikawa, H., (1982). Reversible osmotic opening of the blood-brain barrier: Prevention of tissue damage with filtration of the perfusate. Acta Pathol. Jpn. 32:427-435.
85. Tomiwa, K., Hazama, F., and Mikawa, H. (1983). Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier. Neuropathol. Appl. Neurobiol. 9:345-354.
86. Walker, M. (1977). Treatment of brain tumors. Med. Clin. North Am. 61:1045-1051.
87. Warnke, P. C., Blasberg, R. G., and Groothuis, D. R. (1987). The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas. Ann. Neurol. 22:300-305.
88. Westergren, I., and Johansson, B. B. (1993). Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: A comparison between protamine, poly-L-lysine and poly-L-arginine. Acta Physiol. Scand. 149:99-104.
89. Wielbo, D., Sernia, C., Gyurko, R., and Phillips, M. I. (1995). Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension 25:314-319.
90. Williams, P. C., Henner, W. D., Roman-Goldstein, S., Dahlborg, S. A., Brummett, R. E., Tableman, M., Dana, B. W., and Neuwelt, E. A. (1995). Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery 37:17-28.
91. Williams, W. M., Chang, M. C., and Rapoport, S. I. (1994). Cerebral microvessel phospholipase A2 activity in senescent mouse. Neurochem. Res. 19:317-320.
92. Wong, A. J., and Gotleib, A. I. (1986). Endothelial cell monolayer integrity. I. Characterization of dense peripheral band of microfilaments. Arteriosclerosis 6:212-219.
93. Yang, W., Barth, R. F., Carpenter, D. P., Moeschberger, M. L., and Goodman, J. H. (1996). Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery 38:965-992.
94. 3H-inulin after osmotic opening in the rat. Exp. Neurol. 79:845-857.
95. Ziylan, Y. Z., Robinson, P. J., and Rapoport, S. I. (1984). Blood-brain barrier permeability to sucrose and dextran after osmotic opening. Am. J. Physiol. 247:R634-R638.
96. Zlokovic, B. V., and Apuzzo, M. L. J. (1997). Cellular and molecular neurosurgery: Pathways from concept to reality - Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 40:805-813.
97. Zunkeler, B., Carson, R. E., Olson, J., Blasberg, R. G., Girton, M., Bacher, J., Herscovitch, P., and Oldfield, E. H. (1996a). Hyperosmolar blood-brain barrier disruption in baboons: An in vivo study using positron emission tomography and rubidium-82. J. Neurosurg. 84:494-502.
98. Zunkeler, B., Carson, R. E., Olson, J., Blasberg, R. G., DeVroom, H., Lutz, R. J., Saris, S. C., Wright, D. C., Kammerer, W., Patronas, N. J., Dedrick, R. L., Herscovitch, P., and Oldfield, E. H. (1996b). Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J. Neurosurg. 85:1056-1065.